TUBA1C and testicular cancer: Similar to the results in Oncomine, TUBA1C was upregulated in most cancers, including BLCA, BRCA, CESC, COAD, large B-cell lymphoma (DLBC), GBM, LGG, LIHC, LUAD, lung squamous cell carcinoma (LUSC), OV, PAAD, rectal cancer (READ), stomach cancer (STAD), testicular cancer (TGCT), thymoma (THYM), endometrioid cancer (UCEC) and uterine carcinosarcoma (UCS).